Case number 2:21-cv-19466
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 22, 2022 | N/A | Terminated Case (0) Docket Text: ***Civil Case Terminated without prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i). (nic, ) |
| Mar 21, 2022 | 15 | Stipulation of Dismissal (aty) (2) Docket Text: STIPULATION of Dismissal by NEUROCRINE BIOSCIENCES, INC.. (ARTILES, GUILLERMO) |
| Feb 14, 2022 | N/A | Update Answer Due Deadline (0) Docket Text: Clerk`s Text Order - The document [13] Stipulation filed by ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS HEALTHCARE (USA) LLC submitted by ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS HEALTHCARE (USA) LLC has been GRANTED. The answer due date has been set for 3/22/2022. (qa, ) |
| Feb 14, 2022 | 14 | Order (2) Docket Text: ORDER that the Defendants' time to answer, move, or otherwise respond to the Complaint is hereby extended through and including March 22, 2022, re [13] Stipulation. Signed by Judge Kevin McNulty on 2/14/2022. (qa, ) |
| Feb 11, 2022 | 12 | Notice of Appearance (3) Docket Text: NOTICE of Appearance by ZHIBIN LI on behalf of CADILA HEALTHCARE LIMITED, ZYDUS HEALTHCARE (USA) LLC, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC (LI, ZHIBIN) |
| Feb 11, 2022 | 13 | Stipulation (2) Docket Text: STIPULATION AND PROPOSED ORDER TO EXTEND TIME TO ANSWER, OR OTHERWISE RESPOND TO THE COMPLAINT by ZYDUS HEALTHCARE (USA) LLC, ZYDUS PHARMACEUTICALS (USA) INC.. (LI, ZHIBIN) |
| Jan 27, 2022 | 10 | Affidavit of Service (1) Docket Text: AFFIDAVIT of Service on 1/25/2022, filed by NEUROCRINE BIOSCIENCES, INC.. (ARTILES, GUILLERMO) |
| Jan 27, 2022 | 11 | Affidavit of Service (1) Docket Text: AFFIDAVIT of Service on 1/25/2022, filed by NEUROCRINE BIOSCIENCES, INC.. (ARTILES, GUILLERMO) |
| Jan 25, 2022 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by NEUROCRINE BIOSCIENCES, INC.. (ARTILES, GUILLERMO) |
| Jan 25, 2022 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by NEUROCRINE BIOSCIENCES, INC.. (ARTILES, GUILLERMO) |
| Jan 25, 2022 | 9 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE Returned Executed by NEUROCRINE BIOSCIENCES, INC.. (ARTILES, GUILLERMO) |
| Nov 18, 2021 | 6 | Summons Issued (2) Docket Text: SUMMONS ISSUED as to CADILA HEALTHCARE LIMITED, ZYDUS HEALTHCARE (USA) LLC, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (qa, ) |
| Nov 4, 2021 | 5 | Main Document (1) Docket Text: AO120 Patent Form filed. (Attachments: # (1) Complaint and Exhibits) (qa, ) |
| Nov 4, 2021 | 5 | Complaint and Exhibits (133) |
| Nov 2, 2021 | N/A | Add and Terminate Judges (0) Docket Text: Judge Kevin McNulty and Magistrate Judge Jessica S. Allen added. (ps) |
| Nov 2, 2021 | 4 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by MATTHEW ADAM SKLAR on behalf of NEUROCRINE BIOSCIENCES, INC. (SKLAR, MATTHEW) |
| Oct 29, 2021 | 1 | Main Document (21) Docket Text: COMPLAINT against CADILA HEALTHCARE LIMITED, ZYDUS HEALTHCARE (USA) LLC, ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC ( Filing and Admin fee $ 402 receipt number ANJDC-12939649) , Related Case Selected, filed by NEUROCRINE BIOSCIENCES, INC.. (Attachments: # (1) Exhibit Exhibit A, # (2) Exhibit Exhibit B, # (3) Exhibit Exhibit C, # (4) Exhibit Exhibit D, # (5) Civil Cover Sheet, # (6) AO 120, # (7) Certification Rule 11.2 Certification, # (8) Certification Rule 201.1 Certification)(ARTILES, GUILLERMO) |
| Oct 29, 2021 | 1 | Exhibit Exhibit A (33) |
| Oct 29, 2021 | 1 | Exhibit Exhibit B (27) |
| Oct 29, 2021 | 1 | Exhibit Exhibit C (23) |
| Oct 29, 2021 | 1 | Exhibit Exhibit D (29) |
| Oct 29, 2021 | 1 | Civil Cover Sheet (1) |
| Oct 29, 2021 | 1 | AO 120 (1) |
| Oct 29, 2021 | 1 | Certification Rule 11.2 Certification (3) |
| Oct 29, 2021 | 1 | Certification Rule 201.1 Certification (2) |
| Oct 29, 2021 | 2 | Corporate Disclosure Statement (aty) (2) Docket Text: Corporate Disclosure Statement by NEUROCRINE BIOSCIENCES, INC.. (ARTILES, GUILLERMO) |
| Oct 29, 2021 | 3 | Amended Document (1) Docket Text: AMENDED DOCUMENT by NEUROCRINE BIOSCIENCES, INC.. CIVIL COVER SHEET (CORRECTED). (ARTILES, GUILLERMO) |
| Oct 29, 2021 | 1 | Complaint* (1) |
